A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.

NCT07058662 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

DMD

Interventions

GENETIC: Single dose intravenous of BBM-D101

Sponsor

Belief BioMed (Beijing) Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]